{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:33:00Z","timestamp":1765233180831,"version":"3.43.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Granulocyte transfusions have long been used to bridge the time to neutrophil recovery in patients with neutropenia and severe infection. Recent randomized controlled trials did not prove a beneficial effect of granulocyte transfusions, but were likely underpowered and suffered from very heterogeneous study populations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively reviewed data of all patients treated with granulocyte transfusions at our pediatric center from 2004 to 2019. To identify parameters that predict the success of granulocyte transfusions, we stratified patients in 3 groups. Patients in group 1 cleared their infection, whereas patients in group 2 succumbed to an infection in neutropenia despite granulocyte transfusions. A third group included all patients who died of causes that were not related to infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We demonstrate that patients without respiratory or cardiocirculatory insufficiency are enriched in group 1 and more likely to benefit from granulocyte transfusions than patients who already require these intensive care measures. The effect of granulocyte transfusions correlates with the cell dose per body weight applied per time. With our standard twice weekly dosing, patients with a body weight below 40\u2009kg are more likely to achieve a sufficient leukocyte increment and clear their infection in comparison to patients with a higher body weight.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion\/Conclusions:<\/jats:title>\n            <jats:p>We suggest that future studies on the benefits of granulocyte transfusions stratify patients according to clinical risk factors that include the need for respiratory or cardiocirculatory support and strive for a sufficient dose density of granulocyte transfusions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002349","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T16:00:33Z","timestamp":1635264033000},"page":"e968-e975","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and Oncology"],"prefix":"10.1097","volume":"44","author":[{"given":"Pascal D.","family":"Johann","sequence":"first","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Swabian Childrens\u2019 Cancer Center, University Childrens\u2019 Hospital Augsburg and EU-RHAB Registry, Augsburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service Baden-W\u00fcrttemberg\u2013Hessen, Medical Faculty Mannheim, Heidelberg University, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Trojanova","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service Baden-W\u00fcrttemberg\u2013Hessen, Medical Faculty Mannheim, Heidelberg University, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Sturm","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Hai-Ning","family":"Lu","sequence":"additional","affiliation":[{"name":"DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center"},{"name":"Department of Pediatric Hematology and Oncology, Clinic of Pediatrics III, University Hospital Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), University of Heidelberg, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim B.","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), University of Heidelberg, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13613-016-0189-6","article-title":"Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)","volume":"6","author":"Schnell","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/trf.14994","article-title":"The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions","volume":"59","author":"Netelenbos","year":"2019","journal-title":"Transfusion"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jcyt.2017.08.012","article-title":"Granulocyte transfusions: a concise review for practitioners","volume":"19","author":"Gea-Banacloche","year":"2017","journal-title":"Cytotherapy"},{"key":"R5-20250804","first-page":"CD005339","article-title":"Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction","volume":"4","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250804","first-page":"CD005341","article-title":"Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction","volume":"2015","author":"Massey","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.14597","article-title":"Granulocyte transfusions in the management of invasive fungal infections","volume":"177","author":"West","year":"2017","journal-title":"Br J Haematol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jca.21818","article-title":"Efficacy and safety of granulocyte transfusion in children: a single-center experience","volume":"35","author":"Kagizmanli","year":"2020","journal-title":"J Clin Apher"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5045\/br.2019.54.1.52","article-title":"Analysis of hematologic parameters of donors, patients, and granulocyte concentrates to predict successful granulocyte transfusion","volume":"54","author":"Lee","year":"2019","journal-title":"Blood Res"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"e0209832","DOI":"10.1371\/journal.pone.0209832","article-title":"Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: experience from a tertiary care centre in North India","volume":"13","author":"Garg","year":"2018","journal-title":"PLoS One"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00431-016-2774-y","article-title":"Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis","volume":"175","author":"Weingarten","year":"2016","journal-title":"Eur J Pediatr"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"e0159569","DOI":"10.1371\/journal.pone.0159569","article-title":"Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia","volume":"11","author":"Teofili","year":"2016","journal-title":"PLoS One"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MPH.0b013e318196a6f9","article-title":"Granulocyte transfusions in children and young adults: does the dose matter?","volume":"31","author":"Seidel","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20250804","first-page":"910","article-title":"G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/trf.15025","article-title":"Therapeutic granulocyte transfusions: neutropenic patients with acute leukemia continue to need them\u2014why are definitive evidence-based practice guidelines elusive?","volume":"59","author":"Strauss","year":"2019","journal-title":"Transfusion"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1774-9987.2005.00227.x","article-title":"Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis","volume":"9","author":"Ikinciogullari","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:03:52Z","timestamp":1754337832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002349","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"2021-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}